Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Captain T Cell logo — Next-Generation T cells for solid tumor patients

Captain T Cell

Next-Generation T cells for solid tumor patients

Founded 2019 Germany Schonefeld, Germany 15 employees Seed Total: $8.50M Health Care, Health and Wellness

General Information

Company Name Captain T Cell
Founded Year 2019
Location Germany Schonefeld, Germany
Employees 15
Industries Health Care, Health and Wellness
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Captain T Cell. To contact Captain T Cell, visit captaintcell.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Captain T Cell compare?

A PDF of Captain T Cell and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Captain T Cell soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Captain T Cell

Captain T Cell develops first-in-class, efficacy-enhanced T cell therapies against solid tumors that are not addressed by existing treatments. Captain T Cell generates next-generation TCR-T cells with enhanced persistence and the capacity to cope with the hostile tumor microenvironment of difficult-to-treat solid tumors. In addition, the company has established a novel allogeneic platform to enable off-the-shelf treatments of solid tumors. Captain T Cell is based in Schoenefeld/Berlin, Germany, and backed by leading European investors i&i Biotech Fund I SCSp, Brandenburg Kapital GmbH, and HIL-INVENT Ges.m.b.H. Captain T Cell was founded by a dedicated team of immuno-oncology experts using technology developed at the Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round €8.50M 3
BC Brandenburg Capital
BC Brandenburg Capital, Hil-Invent +1
22 May 2024

Latest News

View All
From blood tests to orbital labs: Europe’s next generation of cancer tech — Tech
From blood tests to orbital labs: Europe’s next generation of cancer tech
Tech Feb 04, 2026
Startupnews zum Wochenende KW 47/25 — Startbase.de
Startupnews zum Wochenende KW 47/25
Startbase.de Nov 21, 2025

FAQ About Captain T Cell

Next-Generation T cells for solid tumor patients
Captain T Cell was founded in 2019.
Captain T Cell is headquartered in Schonefeld, Germany.
Captain T Cell operates in Health Care and Health and Wellness.
Captain T Cell has approximately 15 employees.
Captain T Cell has completed 1 funding round, raising a total of $8.50M. The latest funding stage is Seed.

Source: BounceWatch company record for Captain T Cell, https://bouncewatch.com/company/captain-t-cell, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout